Literature DB >> 24965460

Broadly neutralizing antibody VRC01 prevents HIV-1 transmission from plasmacytoid dendritic cells to CD4 T lymphocytes.

Bin Su1, Alexandre Lederle2, Géraldine Laumond3, Camille Ducloy3, Sylvie Schmidt3, Thomas Decoville3, Christiane Moog1.   

Abstract

Plasmacytoid dendritic cells (pDC) poorly replicate human immunodeficiency virus type 1 (HIV-1) but efficiently transfer HIV-1 to adjacent CD4 T lymphocytes. We found that coculture with T lymphocytes downregulates SAMHD1 expression, enhances HIV-1 replication, and increases pDC maturation and alpha interferon (IFN-α) secretion. HIV-1 transfer to T lymphocytes is inhibited by broadly neutralizing antibody VRC01 with efficiency similar to that of cell-free infection of T lymphocytes. Interestingly, prevention of HIV-1 transmission by VRC01 retains IFN-α secretion. These results emphasize the multiple functions of VRC01 in protection against HIV-1 acquisition.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24965460      PMCID: PMC4178849          DOI: 10.1128/JVI.01748-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

Review 1.  Crosstalk between T lymphocytes and dendritic cells.

Authors:  Claire Hivroz; Karine Chemin; Marie Tourret; Armelle Bohineust
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 2.  Cellular and viral mechanisms of HIV-1 transmission mediated by dendritic cells.

Authors:  Christopher M Coleman; Corine St Gelais; Li Wu
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 3.  Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies.

Authors:  Peter D Kwong; John R Mascola
Journal:  Immunity       Date:  2012-09-21       Impact factor: 31.745

4.  Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model.

Authors:  Milena Veselinovic; C Preston Neff; Leila R Mulder; Ramesh Akkina
Journal:  Virology       Date:  2012-07-24       Impact factor: 3.616

5.  Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation.

Authors:  Lawrence Fong; Manuela Mengozzi; Nancy W Abbey; Brian G Herndier; Edgar G Engleman
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies.

Authors:  Irene A Abela; Livia Berlinger; Merle Schanz; Lucy Reynell; Huldrych F Günthard; Peter Rusert; Alexandra Trkola
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

7.  Innate sensing of HIV-infected cells.

Authors:  Alice Lepelley; Stéphanie Louis; Marion Sourisseau; Helen K W Law; Julien Pothlichet; Clémentine Schilte; Laurence Chaperot; Joël Plumas; Richard E Randall; Mustapha Si-Tahar; Fabrizio Mammano; Matthew L Albert; Olivier Schwartz
Journal:  PLoS Pathog       Date:  2011-02-17       Impact factor: 6.823

8.  Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein.

Authors:  Kasia Hrecka; Caili Hao; Magda Gierszewska; Selene K Swanson; Malgorzata Kesik-Brodacka; Smita Srivastava; Laurence Florens; Michael P Washburn; Jacek Skowronski
Journal:  Nature       Date:  2011-06-29       Impact factor: 49.962

9.  Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys.

Authors:  Dan H Barouch; James B Whitney; Brian Moldt; Florian Klein; Thiago Y Oliveira; Jinyan Liu; Kathryn E Stephenson; Hui-Wen Chang; Karthik Shekhar; Sanjana Gupta; Joseph P Nkolola; Michael S Seaman; Kaitlin M Smith; Erica N Borducchi; Crystal Cabral; Jeffrey Y Smith; Stephen Blackmore; Srisowmya Sanisetty; James R Perry; Matthew Beck; Mark G Lewis; William Rinaldi; Arup K Chakraborty; Pascal Poignard; Michel C Nussenzweig; Dennis R Burton
Journal:  Nature       Date:  2013-10-30       Impact factor: 49.962

10.  Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission.

Authors:  Marine Malbec; Françoise Porrot; Rejane Rua; Joshua Horwitz; Florian Klein; Ari Halper-Stromberg; Johannes F Scheid; Caroline Eden; Hugo Mouquet; Michel C Nussenzweig; Olivier Schwartz
Journal:  J Exp Med       Date:  2013-11-25       Impact factor: 14.307

View more
  8 in total

1.  Progress towards an HIV cure: update from the 2014 International AIDS Society Symposium.

Authors:  Jenny Louise Anderson; Rémi Fromentin; Giulio Maria Corbelli; Lars Østergaard; Anna Laura Ross
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

2.  Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption.

Authors:  Julie L Mitchell; Hiroshi Takata; Roshell Muir; Donn J Colby; Eugène Kroon; Trevor A Crowell; Carlo Sacdalan; Suteeraporn Pinyakorn; Suwanna Puttamaswin; Khunthalee Benjapornpong; Rapee Trichavaroj; Randall L Tressler; Lawrence Fox; Victoria R Polonis; Diane L Bolton; Frank Maldarelli; Sharon R Lewin; Elias K Haddad; Praphan Phanuphak; Merlin L Robb; Nelson L Michael; Mark de Souza; Nittaya Phanuphak; Jintanat Ananworanich; Lydie Trautmann
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

3.  Pharmacokinetics and Preliminary Safety of Pod-Intravaginal Rings Delivering the Monoclonal Antibody VRC01-N for HIV Prophylaxis in a Macaque Model.

Authors:  Chunxia Zhao; Manjula Gunawardana; Francois Villinger; Marc M Baum; Mariana Remedios-Chan; Thomas R Moench; Larry Zeitlin; Kevin J Whaley; Ognian Bohorov; Thomas J Smith; Deborah J Anderson; John A Moss
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

4.  Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.

Authors:  Bin Su; Maryse Peressin; Camille Ducloy; Julien Penichon; Luzia M Mayr; Géraldine Laumond; Sylvie Schmidt; Thomas Decoville; Christiane Moog
Journal:  AIDS Res Hum Retroviruses       Date:  2015-09-10       Impact factor: 2.205

5.  Complement-Opsonized HIV-1 Overcomes Restriction in Dendritic Cells.

Authors:  Wilfried Posch; Marion Steger; Ulla Knackmuss; Michael Blatzer; Hanna-Mari Baldauf; Wolfgang Doppler; Tommy E White; Paul Hörtnagl; Felipe Diaz-Griffero; Cornelia Lass-Flörl; Hubert Hackl; Arnaud Moris; Oliver T Keppler; Doris Wilflingseder
Journal:  PLoS Pathog       Date:  2015-06-29       Impact factor: 6.823

Review 6.  Non-Neutralizing Antibodies Directed against HIV and Their Functions.

Authors:  Luzia M Mayr; Bin Su; Christiane Moog
Journal:  Front Immunol       Date:  2017-11-20       Impact factor: 7.561

Review 7.  HIV-1 cell-to-cell transmission and broadly neutralizing antibodies.

Authors:  Jérémy Dufloo; Timothée Bruel; Olivier Schwartz
Journal:  Retrovirology       Date:  2018-07-28       Impact factor: 4.602

8.  The importance of semen leukocytes in HIV-1 transmission and the development of prevention strategies.

Authors:  Mariangela Cavarelli; Roger Le Grand
Journal:  Hum Vaccin Immunother       Date:  2020-07-02       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.